244 results
8-K
EX-99.1
JAZZ
Jazz Pharmaceuticals plc
1 May 24
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results
4:06pm
and development
% of total revenues
Acquired in-process research and development
Income tax expense (benefit)1
Effective tax rate 1
1.The GAAP income tax … percentages)
Non-GAAP adjusted:
Cost of product sales
Gross margin
Selling, general and administrative
% of total revenues
Research and development
8-K
EX-99.1
pd1vmletyom6ec
28 Feb 24
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results
4:06pm
8-K
EX-10.1
r5140z1d9 tdgkd
25 Jan 24
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-99.1
7lk9e1dmgb
8 Jan 24
Results of Operations and Financial Condition
7:45am
8-K
EX-99.1
nuthqnwzr5tlmwlisny
8 Nov 23
Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
4:07pm
8-K
EX-99.1
93dkle7
9 Aug 23
Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance
4:07pm
8-K
3lyeycixqrhfh61mf3q1
22 Jun 23
Regulation FD Disclosure
4:05pm
8-K
EX-99.1
cjdwmvzi4yr32uj
10 May 23
Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance
4:08pm